MEMPHIS, Tenn.--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT), today announced the immediate, nationwide availability of Progenix™ DBM Putty, distributed through its wholly-owned subsidiary SpinalGraft Technologies LLC. Progenix DBM Putty is a bone graft substitute and bone void filler used in voids or gaps of the pelvis, ilium, and extremities. Progenix DBM Putty provides excellent handling characteristics while offering surgeons a treatment option with proven bone formation, certified osteoinductivity, validated viral inactivation and device-level sterility.
